Bank of Montreal Can boosted its stake in Agilent Technologies, Inc. (NYSE:A) by 27.9% during the second quarter, according to its most recent disclosure with the SEC. The fund owned 227,044 shares of the medical research company’s stock after buying an additional 49,583 shares during the period. Bank of Montreal Can’s holdings in Agilent Technologies were worth $13,467,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of A. Fox Run Management L.L.C. increased its stake in shares of Agilent Technologies by 111.0% in the first quarter. Fox Run Management L.L.C. now owns 21,947 shares of the medical research company’s stock valued at $1,160,000 after buying an additional 11,547 shares in the last quarter. Private Trust Co. NA increased its stake in shares of Agilent Technologies by 2.1% in the first quarter. Private Trust Co. NA now owns 7,660 shares of the medical research company’s stock valued at $404,000 after buying an additional 161 shares in the last quarter. Capstone Asset Management Co. increased its stake in shares of Agilent Technologies by 7.4% in the first quarter. Capstone Asset Management Co. now owns 43,126 shares of the medical research company’s stock valued at $2,280,000 after buying an additional 2,990 shares in the last quarter. Quadrant Capital Group LLC increased its stake in shares of Agilent Technologies by 0.9% in the first quarter. Quadrant Capital Group LLC now owns 5,470 shares of the medical research company’s stock valued at $284,000 after buying an additional 50 shares in the last quarter. Finally, Gulf International Bank UK Ltd increased its stake in shares of Agilent Technologies by 3.7% in the first quarter. Gulf International Bank UK Ltd now owns 101,706 shares of the medical research company’s stock valued at $5,377,000 after buying an additional 3,600 shares in the last quarter.

Agilent Technologies, Inc. (NYSE:A) opened at 61.37 on Friday. The firm’s 50-day moving average is $60.03 and its 200-day moving average is $54.38. The stock has a market cap of $19.72 billion, a P/E ratio of 34.50 and a beta of 1.30. Agilent Technologies, Inc. has a 12 month low of $42.92 and a 12 month high of $61.84.

Agilent Technologies (NYSE:A) last released its quarterly earnings data on Monday, May 22nd. The medical research company reported $0.58 EPS for the quarter, topping analysts’ consensus estimates of $0.48 by $0.10. The firm had revenue of $1.10 billion during the quarter, compared to the consensus estimate of $1.05 billion. Agilent Technologies had a net margin of 13.41% and a return on equity of 16.49%. The firm’s revenue was up 8.1% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.44 earnings per share. On average, equities analysts forecast that Agilent Technologies, Inc. will post $2.23 earnings per share for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 26th. Shareholders of record on Monday, July 3rd will be issued a $0.132 dividend. This represents a $0.53 dividend on an annualized basis and a yield of 0.86%. The ex-dividend date of this dividend is Thursday, June 29th. Agilent Technologies’s dividend payout ratio is presently 29.78%.

WARNING: “Bank of Montreal Can Has $13.47 Million Stake in Agilent Technologies, Inc. (NYSE:A)” was published by Daily Political and is the sole property of of Daily Political. If you are reading this piece on another website, it was illegally stolen and reposted in violation of United States and international copyright laws. The original version of this piece can be accessed at https://www.dailypolitical.com/2017/07/22/bank-of-montreal-can-has-13-47-million-stake-in-agilent-technologies-inc-nysea.html.

A has been the subject of several recent analyst reports. Deutsche Bank AG restated a “buy” rating and set a $58.00 price objective (up previously from $56.00) on shares of Agilent Technologies in a research report on Sunday, April 2nd. Morgan Stanley boosted their price objective on shares of Agilent Technologies from $65.00 to $70.00 and gave the stock an “overweight” rating in a research report on Wednesday, May 24th. BTIG Research boosted their price objective on shares of Agilent Technologies from $57.00 to $65.00 and gave the stock a “buy” rating in a research report on Wednesday, May 24th. BidaskClub downgraded shares of Agilent Technologies from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, June 13th. Finally, Zacks Investment Research upgraded shares of Agilent Technologies from a “hold” rating to a “buy” rating and set a $63.00 price objective for the company in a research report on Tuesday, May 16th. Two investment analysts have rated the stock with a hold rating, thirteen have issued a buy rating and one has assigned a strong buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and an average target price of $60.12.

In other Agilent Technologies news, Director Heidi Fields sold 8,625 shares of the firm’s stock in a transaction on Friday, June 16th. The stock was sold at an average price of $59.53, for a total value of $513,446.25. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, insider Patrick Kaltenbach sold 5,000 shares of the firm’s stock in a transaction on Thursday, July 13th. The shares were sold at an average price of $61.26, for a total value of $306,300.00. Following the completion of the sale, the insider now owns 45,138 shares in the company, valued at $2,765,153.88. The disclosure for this sale can be found here. Insiders sold 152,119 shares of company stock worth $8,932,719 over the last quarter.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A).

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies Inc. and related companies with MarketBeat.com's FREE daily email newsletter.